Platform Technologies in Drug Discovery and Validation - 1st Edition - ISBN: 9780128130698, 9780128130704

Platform Technologies in Drug Discovery and Validation, Volume 50

1st Edition

Serial Volume Editors: Robert Goodnow
eBook ISBN: 9780128130704
Hardcover ISBN: 9780128130698
Imprint: Academic Press
Published Date: 18th November 2017
Page Count: 690
Sales tax will be calculated at check-out Price includes VAT/GST
175.00
122.50
122.50
122.50
140.00
122.50
122.50
140.00
138.00
96.60
96.60
96.60
110.40
96.60
96.60
110.40
165.00
115.50
115.50
115.50
132.00
115.50
115.50
132.00
183.59
128.51
128.51
128.51
146.87
128.51
128.51
146.87
Unavailable
Price includes VAT/GST
245.41
171.79
171.79
171.79
196.33
171.79
171.79
196.33
165.00
115.50
115.50
115.50
132.00
115.50
115.50
132.00
138.00
96.60
96.60
96.60
110.40
96.60
96.60
110.40
175.00
122.50
122.50
122.50
140.00
122.50
122.50
140.00
Unavailable
Price includes VAT/GST

eBook format help

Institutional Subscription

Support Center

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

1. DNA-Encoded Library Technology: A Brief Guide to Its Evolution and Impact on Drug Discovery

Robert A. Goodnow Jr. and Christopher P. Davie

2. The Chemistry of Oligonucleotide Delivery

David B. Rozema

3. CRISPR–Cas9 for Drug Discovery in Oncology

Sylvie M. Guichard

4. Recent Advances of Microfluidics Technologies in the Field of Medicinal Chemistry

László Ürge, Jesus Alcazar, Lena Huck and György Dormán

5. High-Throughput Screening

Mary Jo Wildey, Anders Haunso, Matthew Tudor, Maria Webb and Jonathan H. Connick

6. Kinase-Centric Computational Drug Development

Albert J. Kooistra and Andrea Volkamer

7. Free Energy Calculation Guided Virtual Screening of Synthetically Feasible Ligand R-Group and Scaffold Modifications: An Emerging Paradigm for Lead Optimization

Robert Abel and Sathesh Bhat

8. Phenotypic Screening

Alleyn T. Plowright and Lauren Drowley

9. Targeted Protein Degradation

Nello Mainolfi and Tim Rasmusson

10. Chemical Biology in Drug Discovery

M. Paola Castaldi, Andrea Zuhl, Piero Ricchiuto and J. Adam Hendricks

11. Fragment-Based Lead Discovery

Ben J. Davis and Stephen D. Roughley

12. Antibody-Drug Conjugates

Amit Kumar, Jason White, R. James Christie, Nazzareno Dimasi and Changshou Gao

13. Antibody-Recruiting Small Molecules: Synthetic Constructs as Immunotherapeutics

Patrick J. McEnaney, Christopher G. Parker and Andrew X. Zhang

14. A Decade of Deuteration in Medicinal Chemistry

Julie F. Liu, Scott L. Harbeson, Christopher L. Brummel, Roger Tung, Robert Silverman and Dario Doller

15. From Natural Peptides to Market

Claudio D. Schteingart and Jolene L. Lau

Description

Platform Technologies in Drug Discovery and Validation, Volume 50, the latest release in the Annual Reports in Medicinal Chemistry series, provides timely and critical reviews of important topics in medicinal chemistry, with an emphasis on emerging topics in the biological sciences. Topics covered in this new volume include DELT, Oligos: ASO, siRNA, CRISPR, Micro-fluidic chemistry, High throughput screening, Kinase-centric computational drug development, Virtual Screening, Phenotypic screening, PROTACS, Chemical Biology, Fragment-based lead generation, Antibody-Drug Conjugates, Antibody-recruiting small molecules, Deuteration, and Peptides.

Key Features

  • Unique for its treatment of platform technologies for medicinal chemistry and target validation
  • Provides a single, rich volume that summaries a broad spectrum of expertise relevant to the field
  • Presents state-of-the-art summaries of platform technologies

Readership

Ideally suited for chemists engaged in multidisciplinary teams for drug discovery including medicinal chemists and others involved in chemical biology and bio-organic disciplines and computational chemistry

Details

No. of pages:
690
Language:
English
Copyright:
© Academic Press 2017
Published:
Imprint:
Academic Press
eBook ISBN:
9780128130704
Hardcover ISBN:
9780128130698

Ratings and Reviews

About the Serial Volume Editors

Robert Goodnow Serial Volume Editor

Robert A. Goodnow, Jr. is currently Vice President, Chemistry Innovation at Pharmaron, Inc in Boston, MA. He completed a Ph.D. in bioorganic chemistry at Columbia University, New York, USA, followed by postdoctoral training at Princeton University, New Jersey, USA. He has worked at Roche and AstraZeneca, focusing on new lead and target discovery as well as implementing chemistry technologies in support of early drug discovery. He is the editor and author of The Handbook of DNA-Encoded Chemistry, which was published in 2014 by Wiley.

Affiliations and Expertise

Pharmaron, Boston, USA

Request Quote

Tax Exemption

We cannot process tax exempt orders online. If you wish to place a tax exempt order please contact us.